Conference Coverage
Conference Coverage
Allopregnanolone May Treat Superrefractory Status Epilepticus Effectively
BALTIMORE—The investigational agent allopregnanolone may effectively treat superrefractory status epilepticus, according to research presented at...
Conference Coverage
Scoring Formula Consolidates Stroke and Bleeding Risk in Patients With Atrial Fibrillation
ROME—A new risk-stratification formula for patients with atrial fibrillation starting oral anticoagulant therapy helps sort out their potential...
Conference Coverage
What’s New in Rare Neuromuscular Disorders?
LAS VEGAS—At the American Academy of Neurology’s Fall 2016 Conference, Robert M. Pascuzzi, MD, presented several case videos to illustrate recent...
Conference Coverage
Cardiac rehab also slashes stroke risk
ROME – Participation in contemporary cardiac rehabilitation programs reduces the risk of a cerebrovascular event by 60%, compared with usual post-...
Conference Coverage
Children’s Drawings of Their Headaches May Indicate Migraine
VANCOUVER—When children depict themselves having a headache, the presence of visual phenomena in their drawings predicts a diagnosis of migraine,...
Conference Coverage
Imaging Markers Predict Neuropsychologic Outcome After Pediatric TBI
VANCOUVER—Early reductions in N-acetylaspartate (NAA) after pediatric traumatic brain injury (TBI) predict neuropsychologic outcomes one year...
Conference Coverage
Neonatal Sleep Measures Predict Neurodevelopmental Outcomes
VANCOUVER—Among newborns at risk of neurologic dysfunction, measures of neonatal sleep help predict 18-month neurodevelopmental outcomes,...
Conference Coverage
How Often Do Children With Epilepsy Have Generalized Tonic–Clonic Seizures?
VANCOUVER—Children with epilepsy have a “remarkable” number of generalized tonic–clonic seizures over 25 years of follow-up, according to a study...
Conference Coverage
VIDEO: Rivaroxaban gives safer protection to atrial fib patients post PCI
NEW ORLEANS – The puzzle of how to safely prevent thrombotic events in patients with atrial fibrillation who receive a coronary stent now has a...
Conference Coverage
VIDEO: Blood pressure and LDL lowering in elderly do not slow cognitive decline
NEW ORLEANS – Patients in their 70s and early 80s get the cardiovascular benefits of statin therapy without increased risk of cognitive decline....
Conference Coverage
VIDEO: PRECISION exonerates celecoxib: cardiovascular risk is no worse than that of nonselective NSAIDs
NEW ORLEANS – The cardiovascular safety profile of the nonsteroidal anti-inflammatory drug (NSAID) celecoxib, a selective inhibitor of COX-2, is...